Levi Strauss & Co.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Nov 30, 2025 · FY), Levi Strauss & Co. reported revenue of $6.3B (-1.2% year on year) and net income of $578.1M (+174.5% year on year).
| Line item | Nov 30, 2025 · FY | Dec 1, 2024 · FY | Nov 26, 2023 · FY | Nov 27, 2022 · FY |
|---|---|---|---|---|
| Net revenues | $6.3B | $6.4B | $6.2B | $6.2B |
| Cost of goods sold | $2.4B | $2.5B | $2.7B | $2.6B |
| Gross profit | $3.9B | $3.8B | $3.5B | $3.5B |
| Selling, general and administrative expenses | $3.2B | $3.2B | $3.1B | $2.9B |
| Restructuring charges, net | $24.5M | $188.7M | — | — |
| Goodwill and other intangible asset impairment charges | $2.5M | $116.9M | $90.2M | — |
| Operating income | $677.6M | $264.1M | $353.3M | $646.5M |
| Interest expense | ($48.6M) | ($41.8M) | ($45.9M) | ($25.7M) |
| Other income (expense), net | $5.0M | ($3.3M) | ($42.2M) | $28.8M |
| Income from continuing operations before income taxes | $634.0M | $219.0M | $265.2M | $649.6M |
| Income tax expense | $132.0M | $8.4M | $15.6M | $80.5M |
| Net income from continuing operations | $502.0M | — | — | — |
| Net income (loss) from discontinued operations, net of taxes | $76.1M | — | — | — |
| Net income | $578.1M | $210.6M | $249.6M | $569.1M |
| Continuing operations - Basic (usd per share) | $1.27 | — | — | — |
| Discontinued operations - Basic (usd per share) | $0.19 | — | — | — |
| Net income - Basic (usd per share) | $1.46 | $0.53 | $0.63 | $1.43 |
| Continuing operations - Diluted (usd per share) | $1.26 | — | — | — |
| Discontinued operations - Diluted (usd per share) | $0.19 | — | — | — |
| Net income - Diluted (usd per share) | $1.45 | $0.52 | $0.62 | $1.41 |
| Basic (in shares) | 395.5M | 398.2M | 397.2M | 397.3M |
| Diluted (in shares) | 399.7M | 402.4M | 401.7M | 403.8M |
| Line item | Aug 30, 2026 · Q1 | May 31, 2026 · Q4 | Mar 1, 2026 · Q4 | Aug 31, 2025 · Q3 |
|---|---|---|---|---|
| Net revenues | $1.6B | $1.6B | $1.7B | $1.5B |
| Cost of goods sold | $543.9M | $582.9M | $664.2M | $591.8M |
| Gross profit | $1.1B | $979.1M | $1.1B | $951.6M |
| Selling, general and administrative expenses | $835.9M | $843.4M | $871.7M | $775.6M |
| Restructuring charges, net | $7.6M | $13.5M | $7.9M | $8.6M |
| Operating income | $222.3M | $122.2M | $198.7M | $167.4M |
| Interest expense | ($12.9M) | ($12.9M) | ($13.1M) | ($12.5M) |
| Other income (expense), net | $10.7M | $12.9M | $42.6M | $1.3M |
| Income from continuing operations before income taxes | $220.1M | $122.2M | $228.2M | $156.2M |
| Income tax expense | $51.5M | $27.4M | $51.1M | $34.2M |
| Net income from continuing operations | $168.6M | $94.8M | $177.1M | $122.0M |
| Net income (loss) from discontinued operations, net of taxes | $0 | ($7.5M) | ($1.3M) | $96.1M |
| Net income | $168.6M | $87.3M | $175.8M | $218.1M |
| Continuing operations - Basic (usd per share) | $0.44 | $0.25 | $0.45 | $0.31 |
| Discontinued operations - Basic (usd per share) | $0.00 | -$0.02 | $0.00 | $0.24 |
| Net income - Basic (usd per share) | $0.44 | $0.23 | $0.45 | $0.55 |
| Continuing operations - Diluted (usd per share) | $0.43 | $0.24 | $0.45 | $0.31 |
| Discontinued operations - Diluted (usd per share) | $0.00 | -$0.02 | $0.00 | $0.24 |
| Net income - Diluted (usd per share) | $0.43 | $0.22 | $0.45 | $0.55 |
| Basic (in shares) | 386.1M | 386.0M | 389.9M | 395.7M |
| Diluted (in shares) | 390.6M | 389.6M | 394.2M | 399.5M |
| Line item | Nov 30, 2025 · FY | Dec 1, 2024 · FY | Nov 26, 2023 · FY | Nov 27, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $757.9M | $690.0M | $398.8M | $429.6M |
| Short-term investments in marketable securities | $90.9M | — | $0 | $70.6M |
| Trade receivables, net | $774.7M | $710.0M | $752.7M | $697.0M |
| Inventories | $1.2B | $1.2B | $1.3B | $1.4B |
| Other current assets | $238.5M | $211.7M | $196.0M | $213.9M |
| Current assets held for sale | $54.0M | — | — | — |
| Total current assets | $3.2B | $2.9B | $2.6B | $2.8B |
| Property, plant and equipment, net | $681.8M | $698.7M | $680.7M | $622.8M |
| Goodwill | $280.6M | $277.6M | $303.7M | $365.7M |
| Other intangible assets, net | $194.4M | $196.6M | $267.6M | $286.7M |
| Deferred tax assets, net | $830.1M | $798.5M | $729.5M | $625.0M |
| Operating lease right-of-use assets, net | $1.1B | $1.1B | $1.0B | $970.0M |
| Other non-current assets | $538.7M | $464.4M | $400.6M | $339.7M |
| Non-current assets held for sale | $21.3M | — | — | — |
| Total assets | $6.8B | $6.4B | $6.1B | $6.0B |
| Accounts payable | $597.6M | $663.4M | $567.9M | $657.2M |
| Accrued salaries, wages and employee benefits | $244.7M | $234.2M | $214.9M | $246.7M |
| Accrued sales returns and allowances | $226.1M | $193.4M | $189.8M | $180.0M |
| Short-term operating lease liabilities | $260.7M | $253.3M | $245.5M | $235.7M |
| Other accrued liabilities | $703.4M | $666.2M | $569.4M | $662.0M |
| Total current liabilities | $2.0B | $2.0B | $1.8B | $2.0B |
| Long-term debt | $1.0B | $994.0M | $1.0B | $984.5M |
| Long-term operating lease liabilities | $1.0B | $960.5M | $913.1M | $859.1M |
| Long-term employee related benefits | $252.7M | $110.0M | $102.2M | $104.9M |
| Other long-term liabilities | $240.2M | $186.4M | $50.3M | $54.6M |
| Total liabilities | $4.6B | $4.4B | $4.0B | $4.1B |
| Common stock — $0.001 par value; 1,200,000,000 Class A shares authorized; 103,620,225 shares and 103,984,741 shares issued and outstanding as of November 30, 2025 and December 1, 2024, respectively; and 422,000,000 Class B shares authorized, 286,756,831 shares and 291,411,568 shares issued and outstanding, as of November 30, 2025 and December 1, 2024, respectively | 400.0K | 400.0K | 400.0K | 400.0K |
| Additional paid-in capital | $788.1M | $732.6M | $686.7M | $625.6M |
| Retained earnings | $1.9B | $1.7B | $1.8B | $1.7B |
| Accumulated other comprehensive loss | ($407.2M) | ($434.5M) | ($390.9M) | ($421.7M) |
| Equity, Attributable to Parent, Total | $2.3B | $2.0B | $2.0B | — |
| Total liabilities and stockholders’ equity | $6.8B | $6.4B | $6.1B | $6.0B |
| Line item | Aug 30, 2026 | May 31, 2026 | Mar 1, 2026 | Aug 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $641.4M | $849.3M | $716.6M | $612.8M |
| Short-term investments in marketable securities | $137.9M | $128.5M | $95.4M | $94.7M |
| Trade receivables, net | $745.2M | $586.2M | $728.9M | $722.9M |
| Inventories | $1.3B | $1.2B | $1.1B | $1.3B |
| Other current assets | $463.7M | $245.3M | $248.0M | $232.4M |
| Current assets held for sale | $0 | $0 | $0 | $57.7M |
| Total current assets | $3.2B | $3.0B | $2.9B | $3.0B |
| Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization | $655.8M | $659.8M | $669.1M | $677.4M |
| Goodwill | $285.0M | $282.0M | $282.4M | $278.8M |
| Other intangible assets, net | $192.9M | $192.8M | $193.6M | $194.7M |
| Deferred tax assets, net | $834.6M | $839.9M | $826.6M | $808.1M |
| Operating lease right-of-use assets, net | $1.2B | $1.1B | $1.2B | $1.1B |
| Other non-current assets | $545.6M | $544.8M | $539.2M | $541.8M |
| Non-current assets held for sale | $0 | $0 | $0 | $19.1M |
| Total assets | $6.9B | $6.6B | $6.6B | $6.7B |
| Accounts payable | $684.8M | $598.5M | $487.6M | $621.4M |
| Accrued salaries, wages and employee benefits | $228.7M | $192.9M | $201.5M | $224.5M |
| Accrued sales returns and allowances | $216.7M | $190.8M | $202.8M | $212.5M |
| Short-term operating lease liabilities | $275.8M | $268.3M | $266.7M | $261.1M |
| Other accrued liabilities | $585.0M | $602.7M | $686.7M | $659.5M |
| Total current liabilities | $2.0B | $1.9B | $1.8B | $2.0B |
| Long-term debt | $1.0B | $1.0B | $1.0B | $1.0B |
| Long-term operating lease liabilities | $1.0B | $984.3M | $1.0B | $987.1M |
| Long-term employee related benefits | $243.3M | $244.3M | $241.2M | — |
| Other long-term liabilities | $225.1M | $230.3M | $231.8M | — |
| Long-Term Debt, Excluding Current Maturities | $1.0B | $1.0B | $1.0B | — |
| Total liabilities | $4.5B | $4.4B | $4.4B | $4.5B |
| Common stock — $0.001 par value; 1,200,000,000 Class A shares authorized, 99,254,572 shares and 103,620,225 shares issued and outstanding as of August 30, 2026 and November 30, 2025, respectively; and 422,000,000 Class B shares authorized, 284,215,167 shares and 286,756,831 shares issued and outstanding, as of August 30, 2026 and November 30, 2025, respectively | 400.0K | 400.0K | 400.0K | 400.0K |
| Additional paid-in capital | $811.8M | $754.9M | $729.5M | $761.2M |
| Accumulated other comprehensive loss | ($361.4M) | ($379.7M) | ($386.7M) | ($405.3M) |
| Retained earnings | $2.0B | $1.9B | $1.9B | $1.8B |
| Total stockholders’ equity | $2.4B | $2.3B | $2.2B | $2.2B |
| Total liabilities and stockholders’ equity | $6.9B | $6.6B | $6.6B | $6.7B |
| Line item | Nov 30, 2025 · FY | Dec 1, 2024 · FY | Nov 26, 2023 · FY | Nov 27, 2022 · FY |
|---|---|---|---|---|
| Net income | $578.1M | $210.6M | $249.6M | $569.1M |
| Depreciation and amortization | $206.3M | $193.2M | $165.3M | $158.9M |
| Goodwill and other intangible asset impairment charges | $2.5M | $116.9M | $90.2M | — |
| Property, plant, equipment and right-of-use asset impairment, and gain/loss on early lease terminations, net | $16.3M | $22.3M | $66.4M | — |
| Gain on sale of business, prior to costs to sell | ($155.6M) | — | — | — |
| Gain on sale of assets | ($8.5M) | — | — | — |
| Realized (gain) loss on foreign currency contracts not designated for hedge accounting | ($24.3M) | — | — | — |
| Realized gain on foreign currency contracts designated for hedge accounting | ($12.4M) | — | — | — |
| Stock-based compensation | $81.6M | $62.8M | $74.4M | $60.8M |
| Benefit from deferred income taxes | ($16.4M) | ($91.1M) | — | — |
| Other, net | $19.7M | $33.2M | $2.4M | $11.6M |
| Net change in operating assets and liabilities | ($157.7M) | $350.5M | ($108.5M) | ($550.3M) |
| Net cash provided by operating activities | $529.6M | $898.4M | $435.5M | $228.1M |
| Proceeds from sale of business | $194.7M | — | — | — |
| Purchases of property, plant and equipment | ($221.4M) | ($227.5M) | ($315.5M) | ($267.1M) |
| Net proceeds from sales of assets | $23.1M | — | — | — |
| Payments to acquire business | $0 | ($34.4M) | ($12.1M) | $0 |
| Proceeds (payments) on settlement of forward foreign exchange contracts not designated for hedge accounting | $24.3M | ($17.4M) | $16.1M | $12.4M |
| Payments to acquire short-term investments | ($135.2M) | $0 | $0 | ($72.8M) |
| Proceeds from sale, maturity and collection of short-term investments | $45.8M | $0 | $70.8M | $93.0M |
| Other investing activities, net | $0 | ($1.8M) | — | ($1.2M) |
| Net cash used for investing activities | ($68.7M) | ($281.1M) | ($240.7M) | ($235.7M) |
| Proceeds from issuance of long-term debt, net of issuance costs | $542.5M | — | $0 | $0 |
| Repayments of long-term debt including extinguishment costs | $550.4M | — | $0 | $0 |
| Proceeds from senior revolving credit facility | $0 | $0 | $200.0M | $404.0M |
| Repayments of senior revolving credit facility | $0 | $0 | ($200.0M) | ($404.0M) |
| Accelerated share repurchase | ($120.0M) | — | — | — |
| Repurchase of common stock | ($30.5M) | ($90.1M) | ($8.1M) | ($175.7M) |
| Tax withholdings on equity awards | ($21.7M) | ($24.7M) | ($22.5M) | ($29.0M) |
| Dividend to stockholders | ($212.9M) | ($198.5M) | ($190.5M) | ($174.3M) |
| Other financing activities, net | ($7.2M) | ($6.0M) | $7.0M | $6.2M |
| Net cash (used for) provided by financing activities | ($400.2M) | ($319.3M) | ($214.1M) | ($365.4M) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | $7.2M | ($6.8M) | ($11.6M) | ($7.6M) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | $67.9M | $291.2M | ($30.9M) | ($380.6M) |
| Beginning cash and cash equivalents | $690.0M | $398.8M | $430.0M | $810.6M |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance | $757.9M | — | — | — |
| Property, plant and equipment acquired and not yet paid at end of period | $51.4M | $65.4M | $59.6M | $93.3M |
| Cash paid for interest during the period | $37.0M | $38.2M | $42.8M | $37.5M |
| Income taxes | $159.8M | $102.3M | $89.3M | $129.3M |
| Line item | Aug 30, 2026 · YTD | May 31, 2026 · YTD | Mar 1, 2026 · Q4 | Aug 31, 2025 · YTD |
|---|---|---|---|---|
| Net income | $431.7M | $263.1M | $175.8M | $420.1M |
| Depreciation and amortization | $167.6M | $112.8M | $55.6M | $151.4M |
| Property, plant, equipment impairment, and early lease terminations, net | $6.7M | $900.0K | — | $15.6M |
| Gain on sale of business, prior to costs to sell | ($33.6M) | ($33.6M) | ($35.1M) | ($155.6M) |
| Stock-based compensation | $58.8M | $40.1M | $15.8M | $67.8M |
| Deferred income taxes | $9.7M | ($2.0M) | $10.5M | $8.2M |
| Other, net | ($7.0M) | ($7.3M) | ($7.6M) | ($13.6M) |
| Net change in operating assets and liabilities | ($48.7M) | $108.3M | ($3.5M) | ($225.1M) |
| Net cash provided by operating activities | $585.2M | $482.3M | $211.5M | $262.8M |
| Proceeds from sale of business | $96.3M | $96.3M | $96.3M | $194.7M |
| Purchases of property, plant and equipment | ($157.9M) | ($99.3M) | ($59.4M) | ($170.3M) |
| Net proceeds from sales of assets | $0 | $0 | — | $22.4M |
| (Payments) proceeds on settlement of forward foreign exchange contracts not designated for hedge accounting, net | ($179.7M) | ($5.1M) | — | $37.1M |
| Payments to acquire short-term investments | ($130.3M) | ($87.6M) | ($26.8M) | ($93.6M) |
| Proceeds from sale, maturity and collection of short-term investments | $84.4M | $50.6M | $22.7M | — |
| Other investing activities, net | ($7.4M) | ($6.4M) | ($6.5M) | $0 |
| Net cash used for investing activities | ($294.6M) | ($51.5M) | $26.3M | ($9.7M) |
| Proceeds from issuance of long-term debt, net of issuance costs | $0 | — | — | $543.8M |
| Repayments of long-term debt | $0 | — | — | ($550.4M) |
| Accelerated share repurchase, including excise tax | ($201.0M) | ($201.0M) | ($200.0M) | ($120.0M) |
| Repurchase of common stock | $0 | $0 | $0 | ($30.5M) |
| Tax withholdings on equity awards | ($34.5M) | ($31.7M) | ($31.1M) | ($20.9M) |
| Dividends to stockholders | ($169.3M) | ($107.7M) | ($53.8M) | ($158.2M) |
| Other financing activities, net | ($800.0K) | ($500.0K) | $800.0K | ($900.0K) |
| Net cash used for financing activities | ($405.6M) | ($340.9M) | ($284.1M) | ($337.1M) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | ($1.5M) | $1.5M | $5.0M | $6.8M |
| Net increase (decrease) in cash and cash equivalents and restricted cash | ($116.5M) | $91.4M | ($41.3M) | ($77.2M) |
| Beginning cash and cash equivalents | $757.9M | $757.9M | $757.9M | $690.0M |
| Ending cash and cash equivalents | $641.4M | $849.3M | $716.6M | $612.8M |
| Property, plant and equipment acquired and not yet paid at end of period | $27.7M | $37.9M | $27.6M | $38.9M |
| Cash paid for income taxes during the period, net of refunds | $142.8M | $105.0M | $28.1M | $119.0M |
Levi Strauss & Co. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.